INVOKANA - 50458-141-90 - (canagliflozin)

Alphabetical Index


Drug Information of INVOKANA

Product NDC: 50458-141
Proprietary Name: INVOKANA
Non Proprietary Name: canagliflozin
Active Ingredient(s): 300    mg/1 & nbsp;   canagliflozin
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of INVOKANA

Product NDC: 50458-141
Labeler Name: Janssen Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA204042
Marketing Category: NDA
Start Marketing Date: 20130329

Package Information of INVOKANA

Package NDC: 50458-141-90
Package Description: 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)

NDC Information of INVOKANA

NDC Code 50458-141-90
Proprietary Name INVOKANA
Package Description 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)
Product NDC 50458-141
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name canagliflozin
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130329
Marketing Category Name NDA
Labeler Name Janssen Pharmaceuticals, Inc.
Substance Name CANAGLIFLOZIN
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of INVOKANA


General Information